$VERV Stock Is up 9% Today. Here's What We See in Our Data.

Quiver QuantitativeFeb 14 10:31 ET

BMO Capital Maintains Verve Therapeutics(VERV.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsFeb 7 07:33 ET · Ratings

Buy Rating for Verve Therapeutics: VERVE-102's Enhanced Safety and Promising Efficacy Boost Investor Confidence

TipRanksFeb 7 07:26 ET · Ratings

We're Hopeful That Verve Therapeutics (NASDAQ:VERV) Will Use Its Cash Wisely

Simply Wall StFeb 5 08:39 ET

Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Verve TherapeuticsJan 29 00:00 ET

Verve Cloud Earned Designation as a Great Place to Work-Certified Company Sixth Year in a Row

PR NewswireJan 27 08:13 ET